287 related articles for article (PubMed ID: 11796430)
21. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
22. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K; Wainwright C; Smyth AR
Cochrane Database Syst Rev; 2013 Dec; (12):CD009530. PubMed ID: 24363033
[TBL] [Abstract][Full Text] [Related]
23. How to use: bacterial cultures in diagnosing lower respiratory tract infections in cystic fibrosis.
Ahmed B; Bush A; Davies JC
Arch Dis Child Educ Pract Ed; 2014 Oct; 99(5):181-7. PubMed ID: 24334311
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
25. Value of serology in predicting Pseudomonas aeruginosa infection in young children with cystic fibrosis.
Douglas TA; Brennan S; Berry L; Winfield K; Wainwright CE; Grimwood K; Stick SM; Sly PD;
Thorax; 2010 Nov; 65(11):985-90. PubMed ID: 20889526
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from cystic fibrosis patients during intravenous antibiotic treatment.
Hentschel J; Jäger M; Beiersdorf N; Fischer N; Doht F; Michl RK; Lehmann T; Markert UR; Böer K; Keller PM; Pletz MW; Mainz JG
BMC Pulm Med; 2014 May; 14():82. PubMed ID: 24885494
[TBL] [Abstract][Full Text] [Related]
27. A bacterial stimulation assay for bronchoalveolar lavage immune cells from young children with cystic fibrosis.
Liu H; Sarkar S; Azzopardi K; Day S; Yeow S; Ranganathan S; Sutton P;
Scand J Immunol; 2021 Jul; 94(1):e13040. PubMed ID: 33759233
[TBL] [Abstract][Full Text] [Related]
28. High peripheral blood th17 percent associated with poor lung function in cystic fibrosis.
Mulcahy EM; Hudson JB; Beggs SA; Reid DW; Roddam LF; Cooley MA
PLoS One; 2015; 10(3):e0120912. PubMed ID: 25803862
[TBL] [Abstract][Full Text] [Related]
29. Increased cytokines in cystic fibrosis patients' upper airways during a new P. aeruginosa colonization.
Jaudszus A; Arnold C; Hentschel J; Hünniger K; Baier M; Mainz JG
Pediatr Pulmonol; 2018 Jul; 53(7):881-887. PubMed ID: 29624919
[TBL] [Abstract][Full Text] [Related]
30. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis.
Noah TL; Black HR; Cheng PW; Wood RE; Leigh MW
J Infect Dis; 1997 Mar; 175(3):638-47. PubMed ID: 9041336
[TBL] [Abstract][Full Text] [Related]
31. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage.
Erdmann N; Schilling T; Hentschel J; Lehmann T; von Bismarck P; Ankermann T; Duckstein F; Baier M; Zagoya C; Mainz JG
Front Immunol; 2022; 13():947359. PubMed ID: 36466839
[TBL] [Abstract][Full Text] [Related]
32. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.
Malhotra S; Hayes D; Wozniak DJ
J Cyst Fibros; 2019 Nov; 18(6):796-803. PubMed ID: 31036488
[TBL] [Abstract][Full Text] [Related]
33. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
[TBL] [Abstract][Full Text] [Related]
34. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
[TBL] [Abstract][Full Text] [Related]
35. Detection of antibodies to Pseudomonas aeruginosa in serum and oral fluid from patients with cystic fibrosis.
Weisner AM; Chart H; Bush A; Davies JC; Pitt TL
J Med Microbiol; 2007 May; 56(Pt 5):670-674. PubMed ID: 17446292
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
Holby N; Olling S
Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
[TBL] [Abstract][Full Text] [Related]
37. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
38. [Routine otorhinolaryngological examination in patients with cystic fibrosis].
Koitschev A; Wolff A; Koitschev C; Preyer S; Ziebach R; Stern M
HNO; 2006 May; 54(5):361-4, 366, 368. PubMed ID: 16172900
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
40. Non-invasive assessment of upper and lower airway infection and inflammation in CF patients.
Fischer N; Hentschel J; Markert UR; Keller PM; Pletz MW; Mainz JG
Pediatr Pulmonol; 2014 Nov; 49(11):1065-75. PubMed ID: 24464968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
